These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4369405)

  • 1. Type 2 hyperprolinemia: absence of delta1-pyrroline-5-carboxylic acid dehydrogenase activity.
    Valle DL; Phang JM; Goodman SI
    Science; 1974 Sep; 185(4156):1053-4. PubMed ID: 4369405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type II hyperprolinemia. Delta1-pyrroline-5-carboxylic acid dehydrogenase deficiency in cultured skin fibroblasts and circulating lymphocytes.
    Valle D; Goodman SI; Applegarth DA; Shih VE; Phang JM
    J Clin Invest; 1976 Sep; 58(3):598-603. PubMed ID: 956388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic evidence for a common enzyme catalyzing the second step in the degradation of proline and hydroxyproline.
    Valle D; Goodman SI; Harris SC; Phang JM
    J Clin Invest; 1979 Nov; 64(5):1365-70. PubMed ID: 500817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta1-pyrroline-5-carboxylate synthase deficiency: neurodegeneration, cataracts and connective tissue manifestations combined with hyperammonaemia and reduced ornithine, citrulline, arginine and proline.
    Baumgartner MR; Rabier D; Nassogne MC; Dufier JL; Padovani JP; Kamoun P; Valle D; Saudubray JM
    Eur J Pediatr; 2005 Jan; 164(1):31-6. PubMed ID: 15517380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proline in fascioliasis: III. Activities of pyrroline-5-carboxylic acid reductase and pyrroline-5-carboxylic acid dehydrogenase in Fasciola.
    Isseroff H; Ertel JC
    Int J Parasitol; 1976 Apr; 6(2):183-8. PubMed ID: 4402
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperprolinemia type II: evidence of the excretion of 3-hydroxy delta 1-pyrroline 5-carboxylic acid.
    Dooley KC; Applegarth DA
    Clin Biochem; 1979 Apr; 12(2):62-5. PubMed ID: 445797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of Thermus thermophilus Delta1-pyrroline-5-carboxylate dehydrogenase.
    Inagaki E; Ohshima N; Takahashi H; Kuroishi C; Yokoyama S; Tahirov TH
    J Mol Biol; 2006 Sep; 362(3):490-501. PubMed ID: 16934832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the Delta1-pyrroline 5-carboxylate dehydrogenase gene cause type II hyperprolinemia.
    Geraghty MT; Vaughn D; Nicholson AJ; Lin WW; Jimenez-Sanchez G; Obie C; Flynn MP; Valle D; Hu CA
    Hum Mol Genet; 1998 Sep; 7(9):1411-5. PubMed ID: 9700195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperprolinemia type II].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):155-7. PubMed ID: 9590014
    [No Abstract]   [Full Text] [Related]  

  • 10. Defective hydroxyproline metabolism in type II hyperprolinemia.
    Goodman SI; Mace JW; Miles BS; Teng CC; Brown SB
    Biochem Med; 1974 Aug; 10(4):329-36. PubMed ID: 4851275
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzymes metabolizing delta1-pyrroline-5-carboxylate in rat tissues.
    Herzfeld A; Mezl VA; Knox WE
    Biochem J; 1977 Jul; 166(1):95-103. PubMed ID: 901423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interconversion of glutamic acid and proline. II. The preparation and properties of delta 1-pyrroline-5-carboxylic acid.
    STRECKER HJ
    J Biol Chem; 1960 Jul; 235():2045-50. PubMed ID: 13835167
    [No Abstract]   [Full Text] [Related]  

  • 13. A radioisotopic assay for delta1-pyrroline-5-carboxylate reductase.
    Phang JM; Downing SJ; Valle D
    Anal Biochem; 1973 Sep; 55(1):266-71. PubMed ID: 4753151
    [No Abstract]   [Full Text] [Related]  

  • 14. Catabolic path of arginine and NAD regeneration in the parasite Fasciola hepatica.
    Kurelec B
    Comp Biochem Physiol B; 1975 Jun; 51(2):151-6. PubMed ID: 166790
    [No Abstract]   [Full Text] [Related]  

  • 15. Dicarboxylic aminoaciduria: an inborn error of glutamate and aspartate transport with metabolic implications, in combination with a hyperprolinemia.
    Teijema HL; van Gelderen HH; Giesberts MA; Laurent de Angulo MS
    Metabolism; 1974 Feb; 23(2):115-23. PubMed ID: 4810805
    [No Abstract]   [Full Text] [Related]  

  • 16. Type II hyperprolinemia: a case report.
    Onenli-Mungan N; Yüksel B; Elkay M; Topaloğlu AK; Baykal T; Ozer G
    Turk J Pediatr; 2004; 46(2):167-9. PubMed ID: 15214748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid. Increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II.
    Farrant RD; Walker V; Mills GA; Mellor JM; Langley GJ
    J Biol Chem; 2001 May; 276(18):15107-16. PubMed ID: 11134058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diseases caused by altered intermediate metabolism of amino acids].
    Bulgarelli R; Berio A
    Minerva Nipiol; 1969; 19(6):328-61 contd. PubMed ID: 4923874
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel pyrroline-5-carboxylic acid and acetoacetic acid adduct in hyperprolinaemia type II.
    Walker V; Mills GA; Mellor JM; Langley GJ; Farrant RD
    Clin Chim Acta; 2003 May; 331(1-2):7-17. PubMed ID: 12691858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactions involved in the conversion of ornithine to proline in Clostridia.
    Costilow RN; Laycock L
    J Bacteriol; 1969 Nov; 100(2):662-7. PubMed ID: 4311194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.